Don’t miss the latest developments in business and finance.

Pfizer

Pfizer's shares have fallen more than 9% in the past year and trade at around half of their pandemic-era highs as sales of its COVID products shrink

Updated On: 10 Oct 2024 | 10:43 AM IST

Read served as CEO until Albert Bourla took the position in 2019. Bourla was instrumental in working with BioNTech to develop a COVID-19 vaccine

Updated On: 07 Oct 2024 | 3:29 PM IST

Starboard has also approached Ian Read, a former Pfizer CEO, and Frank D'Amelio, who served as CFO until 2021, and both have expressed interest in helping the activist investor

Updated On: 07 Oct 2024 | 9:35 AM IST

The US company intends to sell 540 million Haleon shares, according to a statement on Monday

Updated On: 01 Oct 2024 | 11:11 PM IST

The northward movement in the rally follows the announcement of a whopping 350 per cent dividend, or Rs 35 per share, for FY24

Updated On: 21 Aug 2024 | 1:01 PM IST

The companies collectively are facing thousands of lawsuits against them in courts across the United States

Updated On: 06 Aug 2024 | 8:03 AM IST

The market for pharmaceutical products used in managing Covid-19 has shrunk by billions of dollars a year, including for Pfizer's vaccines and treatments

Updated On: 30 Jul 2024 | 6:17 PM IST

Not just AstraZeneca, but Pfizer and Roche have also set up their centres in the state

Updated On: 14 Jul 2024 | 11:22 PM IST

Moderna had argued Pfizer and BioNTech copied mRNA advances it had pioneered and patented well before the Covid-19 pandemic began in late 2019

Updated On: 02 Jul 2024 | 5:00 PM IST

The lawsuit filed by Kansas, a US state, alleged that Pfizer promoted its vaccine's safety while hiding evidence linking it to pregnancy complications, such as miscarriages, and heart inflammations

Updated On: 18 Jun 2024 | 5:38 PM IST

Their investment pledges came as President Emmanuel Macron prepared to kick off on Monday the annual 'Choose France' event aimed at wooing big overseas businesses and investors

Updated On: 12 May 2024 | 11:14 PM IST

Financial terms of the settlements were not immediately disclosed for the discontinued over-the-counter drug that was used to treat heartburn

Updated On: 10 May 2024 | 2:27 PM IST

Delhi HC has ordered Renovision Exports to pay Pfizer Rs 3 lakh and issued a permanent injunction preventing the marketing of homoeopathic medicine under the 'VIGOURA' mark

Updated On: 02 May 2024 | 1:00 PM IST

GSK said in the lawsuit that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent rights in mRNA-vaccine innovations developed "more than a decade before" the outbreak of COVID-19

Updated On: 25 Apr 2024 | 8:48 PM IST

The Pfizer INDovation initiative, which has supported 34 startups in India till now, is now expanding its reach through this collaboration with NIPER Ahmedabad

Updated On: 26 Feb 2024 | 6:29 PM IST

Attorneys for Lipitor purchasers including Rochester Drug Co-Operative Inc and Puerto Rico's Drogueria Betances LLC disclosed the agreement in a filing on Wednesday in US court in Trenton, New Jersey

Updated On: 15 Feb 2024 | 11:15 PM IST

Pfizer introduced Lipitor in 1997, and the drug drove more than $130 billion in sales during its first 14 years on the market

Updated On: 15 Feb 2024 | 7:59 AM IST

The prevalence of atopic dermatitis in India has risen over the past three decades, with approximately 5.9 per cent of adults affected, of which 4.4 per cent suffer from a severe form of the disease

Updated On: 31 Jan 2024 | 7:46 PM IST

The New York-based drugmaker earned 10 cents per share on an adjusted basis for the fourth quarter. Analysts on average had expected a loss of 22 cents per share, according to LSEG data

Updated On: 30 Jan 2024 | 9:18 PM IST

Drug firm Pfizer Ltd on Saturday reported 52.11 per cent decline in net profit at Rs 148.96 crore for the second quarter ended September 2023. The company had logged a net profit of Rs 311.07 crore in July-September period a year ago, according to a regulatory filing by Pfizer. Revenue from operations declined 9.76 per cent to Rs 575.21 crore in the quarter as against Rs 637.47 crore in the year-ago period. Total expense was at Rs 410.76 crore, down 5.66 per cent. Total income was at Rs 611.28 crore in September quarter 2023-24, down 7.62 per cent.

Updated On: 28 Oct 2023 | 4:50 PM IST